Details for Patent: 6,150,365
✉ Email this page to a colleague
Summary for Patent: 6,150,365
Title: | Anxiety method |
Abstract: | 6-Hydroxy-8-[4-[4-(2-pyrimidinyl)-piperazinyl]-butyl]-8-azaspiro[4.5]-7,9-d ione and its pharmaceutically acceptable salts and hydrates are useful in the alleviation of anxiety. |
Inventor(s): | Mayol; Robert F. (Durham, CT) |
Assignee: | Bristol-Myers Squibb Company (Princeton, NJ) |
Application Number: | 09/588,221 |
Patent Claim Types: see list of patent claims | Compound; Process; |
Drugs Protected by US Patent 6,150,365
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,150,365
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 028201 | ⤷ Try a Trial | |||
Austria | 300302 | ⤷ Try a Trial | |||
Australia | 1213001 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |